title: Daclizumab has poor efficacy in steroid-refractory severe acute graft-versus-host disease: a single centre experience with 12 allograft patients.
authors.forename: C H
authors.initials: CH
authors.lastname: Hui
authors.forename: H
authors.initials: H
authors.lastname: Sia
authors.forename: H
authors.initials: H
authors.lastname: Mangos
authors.forename: N
authors.initials: N
authors.lastname: Horvath
authors.forename: H
authors.initials: H
authors.lastname: Lee
authors.forename: I
authors.initials: I
authors.lastname: Lewis
authors.forename: T
authors.initials: T
authors.lastname: Hughes
authors.forename: L B
authors.initials: LB
authors.lastname: To
authors.forename: P
authors.initials: P
authors.lastname: Bardy
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000077561:Daclizumab; D005260:Female; D006086:Graft vs Host Disease / Q000188:drug therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008297:Male; D008485:Medical Audit; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D012189:Retrospective Studies; D016879:Salvage Therapy; D014184:Transplantation, Homologous / Q000009:adverse effects; D017211:Treatment Failure
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D000077561:Daclizumab; D008775:Methylprednisolone